Simon Gebremeskel

The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer

Simon Gebremeskel, Terry L. LeVatte, Robert Liwski et al. · International Journal of Cancer · 2014 · 123 citations · Full text

Medicine, Oncology, Pharmacology +16

Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia

Rukhsana Aslam, Yu Hu, Simon Gebremeskel et al. · Blood · 2012 · 112 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody

Simon Gebremeskel, Julia Schanin, Krysta M. Coyle et al. · Frontiers in Immunology · 2021 · 108 citations · Full text

Life Sciences, Immunology, Pathology +17

Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer

Alison J. Gareau, Colin D. Brien, Simon Gebremeskel et al. · Clinical & Experimental Metastasis · 2018 · 97 citations

Medicine, Oncology, Pharmacology +14

Alternatively Activated M2 Macrophages Improve Autologous Fat Graft Survival in a Mouse Model through Induction of Angiogenesis

Kyle D. Phipps, Simon Gebremeskel, Joshua A. Gillis et al. · Plastic & Reconstructive Surgery · 2015 · 82 citations

Life Sciences, Immunology, Plastic Surgery +17